Ad
related to: Moderna
Search results
Moderna to Present at Upcoming Conferences in May/June 2024
The Joplin Globe· 1 day agoA replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation. Moderna is a leader in the creation of the ...
Bull Market and Beyond: 2 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 1 day agoLet's consider two such stocks: Moderna (MRNA 7.13%) and DexCom (DXCM -1.65%). Moderna is one of the...
Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to Know
Zacks· 2 days agoFree Report) is one of the stocks most watched by Zacks.com visitors lately. Over the past month, shares of this biotechnology company have returned +11.6%, compared to the Zacks S&P 500 composite's ...
Is Novavax Stock A Buy After Nearly Tripling On $1.3 Billion Sanofi Deal?
Investor's Business Daily· 2 hours agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via Yahoo News· 4 days agoModerna's shares fell 3% to $119.02 in early trading. The Food and Drug Administration's move...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks· 2 days agoFree Report) were down 4.4% on May 10 after the company announced that the FDA has delayed the review timeline for its mRNA-based, respiratory syncytial virus (RSV) vaccine, mRNA-1345.
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 4 days agoCAMBRIDGE, MA / ACCESSWIRE / May 10, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it has been notified by the U.S. Food and Drug Administration (FDA) that due to administrative ...
Stock Market News for May 14, 2024
Zacks via Yahoo Finance· 4 hours agoThe tech-heavy Nasdaq gained 47.37 points or 0.3% to close at 16,388.24. The major gainer of the Nasdaq Composite was Moderna, Inc. MRNA, after jumping...
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 4 days agoModerna stock toppled Friday after the Food and Drug Administration delayed an approval decision on...
8. ElevateBio
CNBC· 7 hours agoIn a banner 2023, life sciences company ElevateBio struck new biotech R&D collaborations with a former No. 1 Disruptor, Moderna, and high-flying drug...
